Tag - Quthero

Quthero Welcomes Dr. Omar Ibrahimi as Chief Medical Director

Antonette Ho2024-04-06T15:18:12-04:00Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, welcomes Omar Ibrahimi, MD, PhD, a world-renowned dermatologist, to the Quthero team as their Chief Medical Director. Quthero's groundbreaking technology facilitates the complete regeneration of a patient's natural tissue with minimal scarring. Dr. Ibrahimi has served as Quthero's Clinical Advisor and was one of two physicians conducting Quthero's split-face clinical trial on the use of Quthero's post-procedure products on patients undergoing radiofrequency microneedling or laser face resurfacing. Read...

Quthero Secures $500,000 Investment Boost from the Ontario Centre of Innovation

Antonette Ho2024-03-23T17:43:23-04:00Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, proudly announces the successful acquisition of $500,000 in investment funding from the Ontario Centre of Innovation's (OCI) Life Science Innovation Fund. This is in addition to a co-investment of $850,000 for a total round size of $1,350,000. ""Through the Ontario Life Sciences Innovation Fund, our government is ensuring that Ontario companies, like Quthero, have the resources they need to develop cutting-edge solutions,"" said Vic Fedeli, Ontario's Minister of...

Quthero Accepted into Prestigious MaRS-adMare Tx Accelerator

Antonette Ho2023-12-20T14:34:35-05:00Quthero, a biotech company with a unique, patented Q-peptide platform technology was accepted into the MaRS – adMare Therapeutics (Tx) Accelerator which provides a distinctive ecosystem for the development of novel therapeutics in Ontario and Canada. Quthero's technology enables and accelerates full regeneration of a patient's natural tissue with minimal scarring. ""The partnership between MaRS and adMare presents Quthero with a unique opportunity to access the most experienced players in the development of new therapeutics. We are excited...

Skin-care product based on U of T Engineering research donated to health-care workers fighting COVID-19

Ziad2022-11-25T14:02:27-05:00 A U of T Engineering spinoff company has donated its entire stock of skin-care product to health-care workers fighting the global pandemic. Several years ago, Professor Milica Radisic (BME, ChemE) and her team developed a peptide-hydrogel biomaterial that prompts skin cells to “crawl” toward one another. The material was initially designed to help close the chronic, non-healing wounds often associated with diabetes, such as bed sores and foot ulcers. Shortly thereafter, the technology was spun out into Quthero, Inc. a...